Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Commentary Challenges Claims of Exceptional Melflufen Responses in Multiple
2+ hour, 44+ min ago (746+ words) A new commentary published in the Journal of Cancer Research and Clinical Oncology is challenging how exceptional individual responses to an experimental multiple myeloma drug should be interpreted, warning that remarkable case reports can inadvertently obscure evidence that a treatment…...
Lactate Signals and RNA Tags May Shape Post-Hemorrhage Depression, Review
7+ hour, 8+ min ago (55+ words) Intracerebral hemorrhage is the deadliest and most disabling form of stroke, yet some of its cruelest consequences unfold quietly, months or even years after the initial bleed. Survivors frequently develop depression, anxiety, apathy, cognitive impairment, fatigue, and disrupted sleep, symptoms…...
Experts Reach Landmark Consensus on Delivering Intensive Leukemia Drug
10+ hour, 34+ min ago (646+ words) A groundbreaking international consensus effort has, for the first time, established detailed expert guidance on how to safely deliver CPX-351, a liposomal formulation of cytarabine and daunorubicin, to patients with therapy-related acute myeloid leukaemia (t-AML) and acute myeloid leukaemia with…...
AI-enabled clinical trials
1+ day, 46+ min ago (1349+ words) {“title”:”AI-Enabled Clinical Trials Are Poised to Transform How New Medicines Are Tested”,”html”:”Clinical trials have long been the slowest, most expensive and most unpredictable stage of medical research. A promising molecule identified in the laboratory can take a…...
AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus
2+ day, 1+ hour ago (424+ words) Etcamah is a once-daily pill that breaks down the estrogen receptor many breast cancers use to grow and is already approved for a narrower group of breast cancer patients. The setback lands on a pipeline already under scrutiny. Shares of…...
What’s Standing in the Way of More Diverse Clinical Trials? - BlackDoctor - Where Culture Meets Care
1+ day, 16+ hour ago (541+ words) Clinical trials let researchers test new drugs, medical devices, and interventions to improve outcomes across many diseases. But in order for these studies to deliver the most impactful results, they need to include participants from different racial and ethnic backgrounds....
The Sponsor Consensus: How Trial Sponsors Are Thinking About Real-Time Clinical Trials
2+ day, 10+ hour ago (199+ words) Clinical Leader The Sponsor Consensus: How Trial Sponsors Are Thinking About Real-Time Clinical Trials The FDA's Real-Time Clinical Trials (RTCT) initiative aims to shift trial oversight from retrospective, episodic reporting to continuous, real-time review, an effort to compress development timelines…...
Health Canada Clears Updated Clinical Trial Protocol for Redsenol-1 Plus
2+ day, 19+ hour ago (119+ words) Sep 10, 2026, 07:00 ET Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research Since the clinical trial was initiated in 2022, the study has been actively conducted, with some participants having completed the study, providing valuable clinical study data and operational experience....
Pre-Surgery Mental Health Support Improved Recovery
2+ day, 11+ hour ago (177+ words) Sep 10, 2026 | General Healthcare Starting an intervention before surgery that pairs personalized mental health coaching with medication optimization reduces post-surgery depression and anxiety in older adults, according to a clinical trial published in JAMA Network Open. Led by led by researchers…...
David Spetzler: What If We Could Know Which Pancreatic Cancer Treatment Is More Likely to Work? - OncoDaily
2+ day, 12+ hour ago (254+ words) David Spetzler, President of Caris Life Sciences, shared on LinkedIn: “Nearly half the patients in our new pancreatic study received a different first-line treatment than the one our model identified as more likely to benefit them. The research, recently published…...